Superior Planning LLC’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Other funds holding FDMT
Superior Planning LLC's FDMT Position: Q3 2026 in Review
Superior Planning LLC opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 526 shares worth $7.53K. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.
127 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.
- Superior Planning LLC held 526 shares of 4D Molecular Therapeutics worth $7.53K as of Q3 2026.
- 4D Molecular Therapeutics was a new Superior Planning LLC position in Q3 2026.
- 4D Molecular Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #1042 holding.
- 127 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.